InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PLIANT THERAPEUTICS, INC.

PLRX Clue Score31
United States Fiscal year ends December CIK 0001746473 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

116
Insider
Date
Role
Action
Shares
Price
Amount
Minnie Kuo
20 Jan 2026
Chief Operating Officer
Sold on a plan
6,917
$1.28
$8.85K
Bernard Coulie
20 Jan 2026
President and CEO
Sold on a plan
89,375
$1.28
$114.40K
Lily Cheung
20 Jan 2026
Chief Human Resource Officer
Sold on a plan
7,534
$1.28
$9.64K
Keith Lamont Cummings
20 Jan 2026
Chief Financial Officer
Sold on a plan
24,002
$1.28
$30.72K
Mike Ouimette
22 Jan 2025
General Counsel & Corp. Sec'y
Sold on a plan
10,230
$10.99
$112.46K
Mike Ouimette
17 Jan 2025
General Counsel & Corp. Sec'y
Sold on a plan
13,270
$11.20
$148.64K
Lily Cheung
17 Jan 2025
Chief Human Resource Officer
Sold on a plan
3,740
$11.20
$41.89K
Eric Lefebvre
17 Jan 2025
Chief Medical Officer
Sold on a plan
18,478
$11.20
$206.97K
Hans Hull
17 Jan 2025
Chief Business Officer
Sold on a plan
15,936
$11.20
$178.50K
Keith Lamont Cummings
17 Jan 2025
Chief Financial Officer
Sold on a plan
20,148
$11.20
$225.68K
Bernard Coulie
17 Jan 2025
President and CEO
Sold on a plan
52,419
$11.20
$587.15K
Mike Ouimette
10 Jul 2024
General Counsel & Corp. Sec'y
Sold on a plan
7,656
$11.56
$88.50K
Bernard Coulie
10 Jul 2024
President and CEO
Sold on a plan
38,710
$11.56
$447.49K
Keith Lamont Cummings
10 Jul 2024
Chief Financial Officer
Sold on a plan
10,911
$11.56
$126.13K
Hans Hull
10 Jul 2024
Chief Business Officer
Sold on a plan
9,900
$11.56
$114.44K
Eric Lefebvre
10 Jul 2024
Chief Medical Officer
Sold on a plan
12,319
$11.56
$142.41K
Keith Lamont Cummings
2 May 2024
Chief Financial Officer
Exercised, kept
21,000
$2.08
$43.68K
Mike Ouimette
17 Jan 2024
General Counsel & Corp. Sec'y
Sold on a plan
5,197
$17.23
$89.54K
Eric Lefebvre
17 Jan 2024
Chief Medical Officer
Sold on a plan
10,295
$17.23
$177.38K
Bernard Coulie
17 Jan 2024
President and CEO
Sold on a plan
25,721
$17.23
$443.17K
Hans Hull
17 Jan 2024
Chief Business Officer
Sold on a plan
9,786
$17.23
$168.61K
Keith Lamont Cummings
17 Jan 2024
Chief Financial Officer
Sold on a plan
9,781
$17.23
$168.53K
Hans Hull
4 Aug 2023
Chief Business Officer
Sold after exercise
20,050
$20.01
$401.20K
Hans Hull
3 Aug 2023
Chief Business Officer
Sold after exercise
1,800
$20.00
$36.00K
Hans Hull
3 Aug 2023
Chief Business Officer
Sold after exercise
13,069
$20.00
$261.38K
Mike Ouimette
20 Jul 2023
General Counsel & Corp. Sec'y
Sold on a plan
4,755
$17.55
$83.45K
Bernard Coulie
17 Jul 2023
President and CEO
Sold on a plan
70,150
$18.01
$1.26M
Keith Lamont Cummings
17 Jul 2023
Chief Financial Officer
Sold on a plan
19,771
$18.01
$356.06K
Hans Hull
17 Jul 2023
Chief Business Officer
Sold on a plan
17,937
$18.01
$323.03K
Eric Lefebvre
17 Jul 2023
Chief Medical Officer
Sold on a plan
22,321
$18.01
$401.98K
Mike Ouimette
17 Jul 2023
General Counsel & Corp. Sec'y
Sold on a plan
12,778
$18.01
$230.12K
Keith Lamont Cummings
13 Jun 2023
Chief Financial Officer
Exercised, kept
30,750
$2.08
$63.96K
Keith Lamont Cummings
9 Jun 2023
Chief Financial Officer
Exercised, kept
5,800
$2.08
$12.06K
Mike Ouimette
3 Apr 2023
General Counsel & Corp. Sec'y
Sold on a plan
200
$27.46
$5.49K
Mike Ouimette
3 Apr 2023
General Counsel & Corp. Sec'y
Sold on a plan
2,677
$26.74
$71.58K
Bernard Coulie
30 Mar 2023
President and CEO
Sold on a plan
35,339
$26.52
$937.22K
Keith Lamont Cummings
30 Mar 2023
Chief Financial Officer
Sold on a plan
9,960
$26.52
$264.15K
Hans Hull
30 Mar 2023
Chief Business Officer
Sold on a plan
9,036
$26.52
$239.64K
Eric Lefebvre
30 Mar 2023
Chief Medical Officer
Sold on a plan
11,245
$26.52
$298.23K
Mike Ouimette
30 Mar 2023
General Counsel & Corp. Sec'y
Sold on a plan
4,874
$26.52
$129.26K
Bernard Coulie
3 Feb 2023
President and CEO
Sold after exercise
5,262
$34.08
$179.31K
Bernard Coulie
3 Feb 2023
President and CEO
Sold after exercise
9,738
$33.36
$324.89K
Bernard Coulie
2 Feb 2023
President and CEO
Sold after exercise
1,605
$34.96
$56.11K
Bernard Coulie
2 Feb 2023
President and CEO
Sold after exercise
13,395
$34.13
$457.12K
Bernard Coulie
1 Feb 2023
President and CEO
Sold after exercise
105
$35.55
$3.73K
Bernard Coulie
1 Feb 2023
President and CEO
Sold after exercise
5,440
$34.78
$189.19K
Bernard Coulie
1 Feb 2023
President and CEO
Sold after exercise
9,455
$34.15
$322.84K
Bernard Coulie
31 Jan 2023
President and CEO
Sold after exercise
15,000
$34.92
$523.76K
Bernard Coulie
30 Jan 2023
President and CEO
Sold after exercise
3,605
$34.66
$124.94K
Bernard Coulie
30 Jan 2023
President and CEO
Sold after exercise
11,395
$33.98
$387.18K
Bernard Coulie
27 Jan 2023
President and CEO
Sold after exercise indirect
221
$36.64
$8.10K
Bernard Coulie
27 Jan 2023
President and CEO
Sold after exercise indirect
9,779
$35.09
$343.16K
Bernard Coulie
27 Jan 2023
President and CEO
Sold after exercise
6,302
$36.06
$227.24K
Bernard Coulie
27 Jan 2023
President and CEO
Sold after exercise
8,698
$35.42
$308.05K
Bernard Coulie
26 Jan 2023
President and CEO
Sold after exercise indirect
15,000
$35.10
$526.43K
Bernard Coulie
26 Jan 2023
President and CEO
Sold after exercise
15,000
$35.29
$529.37K
Bernard Coulie
25 Jan 2023
President and CEO
Sold after exercise
1,696
$33.29
$56.46K
Bernard Coulie
25 Jan 2023
President and CEO
Sold after exercise
13,304
$32.40
$431.06K
Bernard Coulie
24 Jan 2023
President and CEO
Sold after exercise
15,000
$30.89
$463.39K
Keith Lamont Cummings
23 Jan 2023
Chief Financial Officer
Sold after exercise
30,000
$35.00
$1.05M
Eric Lefebvre
23 Jan 2023
Chief Medical Officer
Sell
67,500
$34.48
$2.33M
Mike Ouimette
23 Jan 2023
General Counsel & Corp. Sec'y
Sold after exercise
20,000
$34.19
$683.88K
Bernard Coulie
23 Jan 2023
President and CEO
Sold after exercise indirect
15,000
$35.00
$525.00K
Bernard Coulie
23 Jan 2023
President and CEO
Sold after exercise
4,850
$34.93
$169.40K
Bernard Coulie
23 Jan 2023
President and CEO
Sold after exercise
10,150
$33.71
$342.16K
Bernard Coulie
9 Jan 2023
President and CEO
Sold after exercise
5,000
$19.17
$95.83K
Bernard Coulie
6 Jan 2023
President and CEO
Sold after exercise
15,000
$19.04
$285.58K
Bernard Coulie
4 Jan 2023
President and CEO
Sold after exercise
15,000
$19.06
$285.94K
Bernard Coulie
3 Jan 2023
President and CEO
Sold after exercise
15,000
$19.33
$289.95K
Mike Ouimette
22 Dec 2022
General Counsel & Corp. Sec'y
Sell
2,928
$19.38
$56.73K
Keith Lamont Cummings
22 Dec 2022
Chief Financial Officer
Exercised, kept
4,000
$2.08
$8.32K
Hans Hull
20 Dec 2022
Chief Business Officer
Sell
8,748
$19.10
$167.11K
Mike Ouimette
20 Dec 2022
General Counsel & Corp. Sec'y
Sell
4,719
$19.10
$90.14K
Eric Lefebvre
20 Dec 2022
Chief Medical Officer
Sell
10,887
$19.10
$207.97K
Bernard Coulie
20 Dec 2022
President and CEO
Sell
34,212
$19.10
$653.53K
Keith Lamont Cummings
20 Dec 2022
Chief Financial Officer
Sell
9,643
$19.10
$184.20K
Eric Lefebvre
25 Oct 2022
Chief Medical Officer
Sell
5,000
$25.05
$125.24K
Bernard Coulie
12 Sep 2022
President and CEO
Sold after exercise
12,502
$22.54
$281.85K
Bernard Coulie
12 Jul 2022
President and CEO
Sold after exercise
12,498
$22.50
$281.21K
Bernard Coulie
11 Jul 2022
President and CEO
Sold after exercise
15,000
$22.50
$337.50K
Eric Lefebvre
11 Jul 2022
Chief Medical Officer
Sell
3,000
$20.00
$60.00K
Keith Lamont Cummings
3 Sep 2021
Chief Financial Officer
Exercised, kept
20,000
$2.08
$41.60K
Eric Lefebvre
18 Jun 2021
Chief Medical Officer
Sell
22
$30.23
$665.06
Eric Lefebvre
18 Jun 2021
Chief Medical Officer
Sell
3,728
$29.43
$109.72K
Eric Lefebvre
18 Jun 2021
Chief Medical Officer
Sell
8,750
$28.62
$250.44K
Bernard Coulie
14 Jun 2021
President and CEO
Sell indirect
243
$33.69
$8.19K
Bernard Coulie
14 Jun 2021
President and CEO
Sell indirect
3,757
$32.98
$123.92K
Hans Hull
26 May 2021
Chief Business Officer
Exercised, kept
4,500
$2.08
$9.36K
Bernard Coulie
14 May 2021
President and CEO
Sell indirect
503
$29.28
$14.73K
Bernard Coulie
14 May 2021
President and CEO
Sell indirect
2,997
$28.53
$85.50K
Bernard Coulie
14 Apr 2021
President and CEO
Sell indirect
3,500
$30.33
$106.16K
Bernard Coulie
13 Apr 2021
President and CEO
Exercised, kept
6,000
$2.08
$12.48K
Eric Lefebvre
18 Mar 2021
Chief Medical Officer
Sell
1,135
$39.78
$45.15K
Eric Lefebvre
18 Mar 2021
Chief Medical Officer
Sell
11,365
$39.38
$447.53K
Bernard Coulie
15 Mar 2021
President and CEO
Sell indirect
178
$39.69
$7.06K
Bernard Coulie
15 Mar 2021
President and CEO
Sell indirect
2,000
$38.75
$77.50K
Bernard Coulie
15 Mar 2021
President and CEO
Sell indirect
1,322
$38.03
$50.27K
Keith Lamont Cummings
5 Mar 2021
Chief Financial Officer
Exercised, kept
20,000
$2.08
$41.60K
Bernard Coulie
16 Feb 2021
President and CEO
Sell indirect
200
$34.07
$6.81K
Bernard Coulie
16 Feb 2021
President and CEO
Sell indirect
2,100
$32.87
$69.02K
Bernard Coulie
16 Feb 2021
President and CEO
Sell indirect
1,200
$32.10
$38.52K
Bernard Coulie
14 Jan 2021
President and CEO
Sell indirect
630
$27.21
$17.15K
Bernard Coulie
14 Jan 2021
President and CEO
Sell indirect
2,870
$26.20
$75.18K
Hans Hull
30 Dec 2020
Chief Business Officer
Exercised, kept
3,500
$2.08
$7.28K
Keith Lamont Cummings
21 Dec 2020
Chief Financial Officer
Exercised, kept
4,500
$2.08
$9.36K
Eric Lefebvre
18 Dec 2020
Chief Medical Officer
Sell
5,712
$26.98
$154.11K
Eric Lefebvre
18 Dec 2020
Chief Medical Officer
Sell
6,788
$26.17
$177.64K
Bernard Coulie
14 Dec 2020
President and CEO
Sell indirect
337
$27.86
$9.39K
Bernard Coulie
14 Dec 2020
President and CEO
Sell indirect
3,163
$27.32
$86.40K
Keith Lamont Cummings
1 Dec 2020
Chief Financial Officer
Sold after exercise
846
$30.72
$25.99K
Keith Lamont Cummings
1 Dec 2020
Chief Financial Officer
Sold after exercise
14,901
$30.21
$450.16K
Keith Lamont Cummings
1 Dec 2020
Chief Financial Officer
Sold after exercise
1,848
$29.07
$53.72K
Keith Lamont Cummings
1 Dec 2020
Chief Financial Officer
Sold after exercise
1,139
$28.24
$32.17K
Bernard Coulie
30 Apr 2020
President and CEO
Exercised, kept
48,227
$2.08
$100.31K
Bernard Coulie
30 Apr 2020
President and CEO
Exercised, kept
613
$6.22
$3.81K
Keith Lamont Cummings
30 Apr 2020
Chief Financial Officer
Exercised, kept
19,300
$2.08
$40.14K

What was left out

Form 4 filings counted 189
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 34
Sales straight out of an exercise 38
Sales at will 31
Transactions with no price 0
Shares from compensation/vesting 16,043,681
Sales filed before the plan box existed 31
History held since 9 Jun 2020